by dhoglund@integrasystems.org | Aug 8, 2012 | Distributed Antenna Systems
Over the next week I will be writing my opinion of the inherent cost and technical challenges of trying to do this with 802.11n, yet alone pending 802.11ac and a risk analysis as via IEC 80001. As a disclaimer….www.solidtechusa.com definitely has the right...
by dhoglund@integrasystems.org | May 23, 2012 | Distributed Antenna Systems, Small Cells
I would have liked to attend this conference, but I just returned from another conference in Las Vegas last week. Definitely what I find the trend is the move to “small cells”…femto and pico cells (the terms) are not really used that much more. The...
by dhoglund@integrasystems.org | Feb 6, 2012 | Design Requirements, Digital Fiber, Distributed Antenna Systems
I have said this for years…but the physics dictate the design.. beyond the hype. The goal here is the overall to save the healthcare system major costs…versus going done a path of a proprietary design that will increase the initial as well as long term...
by dhoglund@integrasystems.org | Feb 1, 2012 | 802.11 WLAN Requirements, Distributed Antenna Systems
I heard about this again today…not again. OK, like anything else if you throw enough $$ at something, custom re-engineer something for what it was not intended, make it proprietary as all get out, and create barriers to the evolution for new wireless LAN...
by dhoglund@integrasystems.org | Jan 27, 2012 | Distributed Antenna Systems
My long time friend Eric who does my SEO (Search Engine Optimization), pointed out to me that if you type into Google….”Distributed Antenna Systems for Healthcare” Integra Systems, comes up first and dominates. The grayed areas are ads. We even come...
by dhoglund@integrasystems.org | Dec 29, 2011 | 802.11 WLAN Requirements, 802.11n, Bi-Directional Amplifiers, Bluetooth, Citrix, Distributed Antenna Systems, EMI, EMR, Femtocell, IEC 800001-1:2010, Machine to Machine Medical Connectivity
It has been a very interesting year and good in the wireless and healthcare connectivity space. A brief re-cap of activities. 1. Developed test plans and protocols as well as conducted testing for a major medical device company (6B). Addressed questions from the FDA...
